-
Needed vaccines unlikely at current funding levels, study says
fiercepharma
December 12, 2018
Despite hundreds of pipeline programs in testing and billions of dollars spent annually...
-
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S.
fiercepharma
December 11, 2018
Three years after?the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the mission of bringing some novel...
-
Emergent and Valneva's Zika vaccine clears phase 1
fiercepharma
December 11, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
-
Why China's flu vaccine supply is suffering this season
fiercepharma
December 11, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down...
-
Anti-vaccine sentiment causing first deaths, expert says
fiercepharma
December 11, 2018
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.?
-
Citing low vaccine trust, experts warn of measles in Philippines
fiercepharma
December 11, 2018
Since Sanofi?disclosed?that its dengue vaccine Dengvaxia can cause more serious infections in certain people, distrust in vaccines has mounted in the Philippines...
-
J&J, Merck chip in for $100M U.K. vaccine center
fiercepharma
December 11, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...
-
Panav Bio-Tech Introduces Classical Swine Fever
expressbpd
December 05, 2018
Himmvac Hog Cholera (T/C) Vaccine by Panav Bio-Tech is the vaccine that is made using Bovine Kidney Cell culture and provides protection against the Hog cholera or classical swine fever
-
FluGen’s broadly protective flu vaccine clears phase 1
fiercepharma
December 04, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains, vaccine effectiveness can be much lower.
-
NIH grants IDT 10-year vaccine manufacturing contract
fiercepharma
December 04, 2018
IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
